Related references
Note: Only part of the references are listed.Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration
Rex Chin Wei Yung et al.
CANCER CYTOPATHOLOGY (2012)
Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis
Guoping Cai et al.
CANCER CYTOPATHOLOGY (2012)
EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection
Sinchita Roy Chowdhuri et al.
MODERN PATHOLOGY (2012)
Lung Cancer: New Biological Insights and Recent Therapeutic Advances
Suresh S. Ramalingam et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
EGFR Gene Status in Cytological Samples of Nonsmall Cell Lung Carcinoma Controversies and Opportunities
Gilda da Cunha Santos et al.
CANCER CYTOPATHOLOGY (2011)
EGFR and KRAS Mutations in Lung Carcinoma Molecular Testing by Using Cytology Specimens
Shahreen Billah et al.
CANCER CYTOPATHOLOGY (2011)
Cytology-Based Gene Mutation Tests to Predict Response to Anti-Epidermal Growth Factor Receptor Therapy: A Review
Umberto Malapelle et al.
DIAGNOSTIC CYTOPATHOLOGY (2011)
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
Paul K. Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
Vicki Leigh Keedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing
Natasha Rekhtman et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR
Ronald van Eijk et al.
PLOS ONE (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Detection of EGFR and KRAS Mutations in Fine-Needle Aspirates Stored on Whatman FTA Cards
Gilda da Cunha Santos et al.
CANCER CYTOPATHOLOGY (2010)
A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases
Sara E. Monaco et al.
HUMAN PATHOLOGY (2010)
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
Robert Pirker et al.
Journal of Thoracic Oncology (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
EGFR Mutations Are Detected Comparably in Cytologic and Surgical Pathology Specimens of Nonsmall Cell Lung Cancer
Jason H. Smouse et al.
CANCER CYTOPATHOLOGY (2009)
EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases
Katharina Schmid et al.
CLINICAL CANCER RESEARCH (2009)
Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas
Jennifer M. Boland et al.
HUMAN PATHOLOGY (2009)
Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer
Sarah Park et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer
Lorenzo Daniele et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
